Key Takeaways:
- The global healthcare logistics market, valued at $96.15 billion in 2025, is projected to grow at a 9.07% compound annual growth rate (CAGR), driven by the complex needs of the biopharmaceutical sector.
- Cold chain logistics is the fastest-growing segment as demand for biologics, mRNA vaccines, and cell therapies increases, requiring specialized, temperature-controlled transportation and storage.
- Outsourcing to third-party logistics (3PL) providers is a dominant strategy, accounting for over 83% of the market as pharmaceutical and biotech companies seek expertise in managing regulatory compliance and complex supply chains.
The global healthcare logistics market is poised for significant expansion, projected to reach $250.17 billion by 2035 from $96.15 billion in 2025, according to a new report from market research firm SNS Insider. This growth reflects a fundamental shift in the healthcare industry, where an increasing volume of high-value, temperature-sensitive biopharmaceuticals is placing new and complex demands on the global supply chain.
Biopharma Boom Fuels Cold Chain Investment
The primary driver behind the market’s 9.07% CAGR is the expanding biopharmaceutical sector, which includes biologics, mRNA vaccines, monoclonal antibodies, and cell and gene therapies. This segment accounted for over 38% of the healthcare logistics market in 2025. Unlike traditional pharmaceuticals, these products often require strict temperature controls throughout their journey from manufacturing to patient delivery.
This necessity is fueling rapid growth in the cold chain segment of the market. While non-cold chain logistics still represents a larger market share at approximately 70%, the report identifies temperature-controlled transportation and cold chain services as the fastest-growing segments. This trend aligns with industry projections, such as those from IQVIA, which estimate that biopharmaceutical drugs will account for more than 35% of global pharmaceutical spending. The operational challenge for businesses is ensuring end-to-end integrity for these sensitive products, driving investment in GDP-compliant warehousing and advanced tracking technologies.
Regional Market Analysis and Strategic Outsourcing
North America currently dominates the healthcare logistics landscape, largely due to the U.S. market, which was valued at $28.92 billion in 2025 and is expected to grow at a CAGR of 11.14%. The region's strength is anchored by its more than $635 billion pharmaceutical industry and a high concentration of biopharmaceutical firms. Europe stands as the second-largest market, with Germany’s robust pharmaceutical manufacturing sector making it a key hub.
However, the Asia-Pacific region is projected to experience the fastest growth, with an expected CAGR of 11.89%. This is largely attributed to strategic initiatives in countries like China, which are bolstering their domestic healthcare and manufacturing capabilities.
To manage the increasing complexity, pharmaceutical and biotechnological companies, which constitute over 63% of the end-user market, are heavily relying on external expertise. The trend toward outsourcing logistics operations to 3PL service providers accounted for more than 83% of the market in 2025. This strategic shift allows drug and device manufacturers to focus on their core competencies while leveraging the specialized infrastructure and regulatory knowledge of logistics partners. While the biopharmaceutical industry is the largest segment, the medical devices sector is forecast to show the highest CAGR of 11.20%, driven by a rising global demand for diagnostic equipment.
